IL-6 is frequently elevated in human gastric cancer and activates STAT3 signaling to promote proliferation, survival, and metastasis; the modest protective effect of IL-6 deletion suggests that other cytokines may compensate for its loss in this model. Here, IL6 is linked to gastric cancer.